tirzepatide cancer π Weight-loss drug shows cancer-fighting potential Researchers at the University of Michigan discovered that (Mounjaro, Zepbound), already FDA-approved for diabetes and obesity, also shrinks breast tumors in obese mice. When Weight-loss jabs 'slash cancer risk
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 8 - Oct 13









.png?w=1280&max-h=720&fit=crop&auto=format)














